Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Gufic Biosciences Limited (NSE: GUFICBIO), ISIN INE742B01025 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
GUFICBIO last traded at ₹436.90 (-1.18%), with a 52-week range of ₹267.50 to ₹466.05 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 72.50%, FIIs 0.46%, DIIs 3.68%, mutual funds 3.43%.
EquiSense Score (ECS): 80/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.